New York Comprehensive Thalassemia Center
Found 5 results
Author Title Type [ Year(Desc)]
Filters: First Letter Of Title is S  [Clear All Filters]
2019
Grace RF, Rose C, D Layton M, Galactéros F, Barcellini W, D Morton H, van Beers EJ, Yaish H, Ravindranath Y, Kuo KHM et al..  2019.  Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency.. N Engl J Med. 381(10):933-944.
Sheth S.  2019.  Stem cell transplantation in sickle-cell disease.. Lancet Haematol. 6(11):e547-e548.
Sheth S.  2019.  Strategies for managing transfusional iron overload: conventional treatments and novel strategies.. Curr Opin Hematol. 26(3):139-144.
2020
Betts M, Flight PA, L Paramore C, Tian L, Milenković D, Sheth S.  2020.  Systematic Literature Review of the Burden of Disease and Treatment for Transfusion-dependent β-Thalassemia.. Clin Ther. 42(2):322-337.e2.
2022
Badawy SM, Kattamis A, Ezzat H, Deschamps B, Sicard E, Fradette C, Zhao F, Tricta F, Tsang YChung, Sheth S et al..  2022.  The safety and acceptability of twice-daily deferiprone for transfusional iron overload: A multicentre, open-label, phase 2 study.. Br J Haematol. 197(1):e12-e15.